Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial

Background: Quercetin, a natural polyphenol with demonstrated broad-spectrum antiviral, anti-inflammatory, and antioxidant properties, has been proposed as an adjuvant for early-stage coronavirus disease 2019 (COVID-19) infection.Objective: To explore the possible therapeutic effect of quercetin in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Francesco Di Pierro, Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, Muhammad Nabeel Akbar Chaudhry, Alexander Bertuccioli, Giuseppe Derosa, Pamela Maffioli, Stefano Togni, Antonella Riva, Pietro Allegrini, Martino Recchia, Nicola Zerbinati
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-01-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	Quercetin COVID-19 SARS-CoV-2 Phytosome® Natural Polyphenols 3CL protease inhibition
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1096853/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!